Navigation Links
Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer

over age 50; more than 7 of 10 men with prostate cancer are over the age of 65.

Advanced prostate cancer means the cancer has spread to tissues next to the prostate, such as the muscles that help control urination, the rectum or the wall of the pelvis. The cancer may have also spread to lymph nodes near the prostate or, if it has metastasized, to other more distant places in the body. With early detection, the five-year survival rate of prostate cancer is almost 100%. But if it has spread, that rate goes down dramatically to 33%.

For full prescribing information, including boxed WARNING, call 800-633- 1610 or visit www.taxotere.com.

About sanofi-aventis

Sanofi-aventis is one of the world leaders in the pharmaceutical industry, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine and vaccines. Sanofi-aventis is listed in Paris and in New York .

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
3. Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
4. Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II trial of Cloretazine (VNP40101M) in Patients with Relapsed or Refractory Small Cell Lung Cancer
5. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
6. Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia Long-Term Safety Data at AAN Annual Meeting
7. Media Advisory: ACC Updated Schedule
8. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
9. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
10. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:8/4/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/bqfsp3/transdermal_drug ... PharmaBiotech,s new report "Transdermal Drug Delivery ... their offering. This report ... approach used to deliver drugs through the ... to oral,intravascular, subcutaneous and transmucosal routes. Various ...
(Date:8/4/2015)... -- Concord Medical Services Holdings Limited ("Concord Medical", or the ... and operator of the largest network of radiotherapy and diagnostic ... it will release its financial results for the second quarter ... Management will hold a conference call to discuss ... August 18, 2015 (8:00 p.m. in Beijing ...
(Date:8/4/2015)... 4, 2015 P&S Market ... overview, trends, DRO analysis, market segmentation, market size ... and top competitor profiles in: Global ... Development and Demand Forecast to 2020  ... Explore full reports with detailed TOC on Global ...
Breaking Medicine Technology:Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 2Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 3Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 4Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 5
... (OTC Bulletin Board: TBIO ) announced today ... Inc.,s (Nasdaq: CLDA ) diagnostic business with ... company has closed on $6.0 million of financing from ... to fund the cash portion of Transgenomic,s acquisition of ...
... FAIRVIEW, Pa., Dec. 29, 2010 Spectrum Control, Inc. (Nasdaq: ... custom electronic products and systems, announced today that it will ... Monday, January 10, 2011, after the close of the market. ... at 4:45 PM, Eastern Time, to discuss the Company,s operating ...
Cached Medicine Technology:Transgenomic Announces Closing of the Acquisition of Clinical Data's Diagnostic Business and the Closing of a $6 Million Financing 2Transgenomic Announces Closing of the Acquisition of Clinical Data's Diagnostic Business and the Closing of a $6 Million Financing 3Transgenomic Announces Closing of the Acquisition of Clinical Data's Diagnostic Business and the Closing of a $6 Million Financing 4
(Date:8/4/2015)... ... August 04, 2015 , ... The ... reproductive health and rights in Indonesia for a select group of U.S.-based journalists ... sites in Indonesia and attend the International Conference on Family Planning in Bali. ...
(Date:8/4/2015)... Angeles, California (PRWEB) , ... August 04, 2015 ... ... drawer slides to Los Angeles commercial customers. Finding reliable hardware can be ... unfortunate liabilities. When putting an office together or designing a new facility, ...
(Date:8/4/2015)... ... August 04, 2015 , ... Worldwide Power Products acquires new ... its reach in Texas. Effective July 1st of this year, Worldwide Power Products ... With the North Texas acquisition, Worldwide Power Products (“WPP”) now services 1000 ...
(Date:8/4/2015)... Horeb, WI (PRWEB) , ... August 04, 2015 , ... ... released video on the subject, Renew Man™ is standing up as a voice of ... 15-year veteran of the healthy aging industry with special experience and expertise in the ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... with “Dr. Google” before calling a physician. In an effort to share more ... health care provider in Pennsylvania to publicly share patient satisfaction ratings and comments ...
Breaking Medicine News(10 mins):Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:North Texas Acquisition Press Release 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3
... DATATRAK International,Inc. (Nasdaq: DATA ), a technology ... clinical trials industry, today announced that,it will host a ... results at 4:30 p.m. ET on Thursday, November 8, ... to dial 412-858-4600 a,few minutes before 4:30 p.m. ET. ...
... million over the next five years to the Center ... Francisco and the Gladstone Institute for Virology and Immunology ... previous five-year award. , The UCSF-GIVI Center ... extending the leadership role of San Francisco in responding ...
... physiologist Jay Hove, PhD, has been named a winner ... Scientists and Engineers (PECASE). , PECASE is recognized as ... United States government. Hove, associate professor of molecular and ... at the White House Thursday, Nov. 1, 2007. He ...
... NEW YORK, Nov. 1 With daylight savings ... another proven pick-me-up in the morning? In,addition to ... also consider,fresh-cut flowers. (See video from the ... at Harvard University and Massachusetts General Hospital,confirmed that ...
... Medical Services,International Inc (Pink Sheets: MSITF) is pleased to announce ... agency related to,its VScan TB test kit showing that it ... in the study, 7 received a rating of most reliable.,The ... to the most reliable,rating, the VScan TB test had a ...
... The Tobacco-Free Kids,Indiana Action Fund launched ... several Indiana communities supporting local elected officials ... Angela,Mansfield (District 2 - D) and Scott ... for their leadership in passing Indianapolis, smoke-free,ordinance. ...
Cached Medicine News:Health News:DATATRAK International Management To Host Conference Call on November 8, 2007 To Discuss Third Quarter and Nine Month Operating Results for 2007 2Health News:DATATRAK International Management To Host Conference Call on November 8, 2007 To Discuss Third Quarter and Nine Month Operating Results for 2007 3Health News:NIH doubles support for vital HIV/AIDS research center 2Health News:University of Cincinnati researcher receives 'highest' honor awarded to young scientists 2Health News:Medical Services Receives Independent Test Results 2Health News:Tobacco-Free Kids Indiana Action Fund Launches Campaign in Support of Angela Mansfield and Scott Keller for Indianapolis City-County Council 2Health News:Tobacco-Free Kids Indiana Action Fund Launches Campaign in Support of Angela Mansfield and Scott Keller for Indianapolis City-County Council 3
Gentle curve facilitates less traumatic removal from eye. Increased length ideal for myopic eyes...
Great for small incisions and excision needs...
Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
2.5mm...
Medicine Products: